Merck Other Current Assets 2010-2024 | MKKGY
Merck other current assets from 2010 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Merck other current assets for the quarter ending June 30, 2024 were $0.857B, a 42.91% decline year-over-year.
- Merck other current assets for 2023 were $0.798B, a 9.11% decline from 2022.
- Merck other current assets for 2022 were $0.878B, a 14.73% decline from 2021.
- Merck other current assets for 2021 were $1.029B, a 17.63% increase from 2020.
Merck Annual Other Current Assets
(Millions of US $) |
| 2023 |
$798 |
| 2022 |
$878 |
| 2021 |
$1,029 |
| 2020 |
$875 |
| 2019 |
$837 |
| 2018 |
$1,046 |
| 2017 |
$826 |
| 2016 |
$746 |
| 2015 |
$551 |
| 2014 |
$2,004 |
| 2013 |
$515 |
| 2012 |
$579 |
| 2011 |
$450 |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Other Current Assets
(Millions of US $) |
| 2024-06-30 |
$857 |
| 2024-03-31 |
$1,130 |
| 2023-12-31 |
$798 |
| 2023-09-30 |
$1,374 |
| 2023-06-30 |
$1,501 |
| 2023-03-31 |
$1,770 |
| 2022-12-31 |
$878 |
| 2022-09-30 |
$1,483 |
| 2022-06-30 |
$1,617 |
| 2022-03-31 |
$1,122 |
| 2021-12-31 |
$1,029 |
| 2021-09-30 |
$1,014 |
| 2021-06-30 |
$890 |
| 2021-03-31 |
$956 |
| 2020-12-31 |
$875 |
| 2020-09-30 |
$1,409 |
| 2020-06-30 |
$747 |
| 2020-03-31 |
$704 |
| 2019-12-31 |
$837 |
| 2019-09-30 |
$1,369 |
| 2019-06-30 |
$1,444 |
| 2019-03-31 |
$1,279 |
| 2018-12-31 |
$1,046 |
| 2018-09-30 |
$773 |
| 2018-06-30 |
$801 |
| 2018-03-31 |
$921 |
| 2017-12-31 |
$826 |
| 2017-09-30 |
$724 |
| 2017-06-30 |
$641 |
| 2017-03-31 |
$660 |
| 2016-12-31 |
$746 |
| 2016-09-30 |
$604 |
| 2016-06-30 |
$617 |
| 2016-03-31 |
$663 |
| 2015-12-31 |
$601 |
| 2015-09-30 |
$482 |
| 2015-06-30 |
$657 |
| 2015-03-31 |
$2,451 |
| 2014-12-31 |
$2,004 |
| 2014-09-30 |
$975 |
| 2014-06-30 |
$584 |
| 2014-03-31 |
$490 |
| 2013-12-31 |
$515 |
| 2013-09-30 |
$478 |
| 2013-06-30 |
$435 |
| 2013-03-31 |
$422 |
| 2012-12-31 |
$579 |
| 2012-09-30 |
$492 |
| 2012-06-30 |
$488 |
| 2012-03-31 |
|
| 2011-12-31 |
$450 |
| 2011-09-30 |
|
| 2011-06-30 |
$597 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
$474 |
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
